【摘要】 目的:比较¹³¹I与抗甲亢药物（ATD）治疗甲亢的疗效。方法:选择首诊的甲亢患者200例,随机分为两组:¹³¹I治疗组与ATD对照组各100例。观察¹³¹I与ATD治疗后突眼、甲减及甲亢复发的情况,并观察¹³¹I与ATD治疗甲亢并发症的疗效及不良反应。结果:¹³¹I与ATD组发生甲减的差异无统计学意义。两组突眼的转归也无差异。¹³¹I治疗复发率明显低于ATD组。¹³¹I治疗甲亢心脏病疗效优于ATD。¹³¹I治疗出现肝损伤、白细胞减少等不良反应低于ATD。结论:¹³¹I治疗甲亢是安全有效的,其综合疗效优于抗甲亢药物。更多还原

【Abstract】 Objective:To investigate the effects of ¹³¹I and anti-thyroid drugs（ATD）on patients with hyperthyroidism.Method: Two hundreds patients with hyperthyroidism were divided into ¹³¹I group（100 cases）and ATD group（100 cases）.A comparison of curative efficacy,incidence of hypothyroidism,relapse and exophthalmos between two groups were performed.Result:The incidence of hypothyroidism and exophthalmos were no statistical difference between two groups（P>0.05）.Compared to ATD group,the incidence of hepatic injury and leukopenia were lower in ¹³¹I group（P<0.05）.¹³¹I was more effective in treatment of hyperthyroid cardiopathy and relapse of hyperthyroidism was lower in ¹³¹I group（P<0.05）.Conclusion:¹³¹I is more effective and safety than anti-thyroid drugs （ATD）in treatment of hyperthyroidism.更多还原